Monday, 21 May 2018
Latest news
Main » Core Laboratories NV (CLB) EPS Estimated At $0.51

Core Laboratories NV (CLB) EPS Estimated At $0.51

17 June 2017

Entegris had 9 analyst reports since August 3, 2015 according to SRatingsIntel. The firm has "Hold" rating given on Friday, March 24 by Tudor Pickering. The firm has "Buy" rating by Needham given on Monday, March 13. More interesting news about Core Laboratories N.V. (NYSE:CLB) were released by: and their article: "5 Things Core Laboratories NV's Management Wants You to Know About What's ..." published on January 30, 2017 as well as's news article titled: "Core Laboratories NV (CLB) CEO David Demshur on Q3 2016 Results - Earnings ..." with publication date: October 20, 2016.

The stock of Core Laboratories N.V. (NYSE:CLB) is a huge mover today! About 3,596 shares traded.

10/06/2016 - D.A. Davidson began new coverage on Core Laboratories N.V. giving the company a "buy" rating. It has underperformed by 22.52% the S&P500. We have $99.21 PT which if reached, will make NYSE:CLB worth $234.50M less.

CSX Corporation (CSX) Analysts See $0.58 EPS
Amica Mutual Insurance Co.'s holdings in CSX Corporation were worth $2,937,000 at the end of the most recent reporting period. Parallel Advisors LLC purchased a new stake in shares of CSX Corporation during the fourth quarter valued at about $114,000.

DST Systems, a provider of technology information processing and servicing solutions. The company has market cap of $741.55 million. It has a 10.24 P/E ratio.

Investors sentiment decreased to 0.85 in Q4 2016. Its down 0.28, from 1.13 in 2016Q3. Citigroup Inc invested in 34,600 shares. Profund Advisors Limited Liability Co, a Maryland-based fund reported 4,471 shares. L P now owns 4,355 shares of the oil and gas company's stock worth $523,000 after buying an additional 76 shares during the period. During the same quarter past year, the firm posted $0.37 earnings per share. 41,511 are owned by Brookstone Capital Mngmt. Millennium Management Ltd Liability Corporation reported 0.04% stake. Bradley Foster & Sargent Ct reported 0.05% stake. Kayne Anderson Rudnick Invest Limited Company accumulated 2.34% or 1.63M shares. Fdx Advisors accumulated 12,272 shares or 0.04% of the stock. Douglass Winthrop Advsr Limited Liability Co has invested 0.12% of its portfolio in Kimberly Clark Corp (NYSE:KMB). Virtu Financial Limited Liability stated it has 2,534 shares or 0.03% of all its holdings.

About 44,976 shares traded. Rocket Fuel Inc (NASDAQ:FUEL) has risen 19.35% since June 12, 2016 and is uptrending. It has outperformed by 61.41% the S&P500.

Amazon buying Whole Foods Market for $13.7 billion
These are likely to be higher income households that traditionally spend the most on cuts of meat and buy expensive brands. The second-largest holder was the Deep Value ETF (DVP), which had 8.45% of its assets in Whole Foods .

Since January 1, 0001, it had 6 buys, and 4 insider sales for $4.32 million activity. $101,676 worth of Entegris Inc (NASDAQ:ENTG) was sold by Sauer Michael. 498,714 shares of the company's stock were exchanged. Marshall Gregory Bryan sold 11,765 shares worth $294,536.

The Firm operates through three divisions: Reservoir Description, Production Enhancement and Reservoir Management. The company has market cap of $1.87 billion. It has a 69.32 P/E ratio. The Reservoir Description segment encompasses the characterization of petroleum reservoir rock, fluid and gas samples.

Since January 30, 2017, it had 2 insider purchases, and 0 selling transactions for $35,617 activity. Carnes Martha Z. had bought 200 shares worth $23,040. ABN Amro upgraded shares of Core Laboratories a hold rating in a research report on Friday, April 21st. Therefore 7% are positive. Earnest Partners LLC owned approximately 4.17% of Core Laboratories N.V. worth $213,011,000 at the end of the most recent reporting period. RBC Capital Markets upgraded Core Laboratories N.V. (NYSE:CLB) on Friday, September 18 to "Outperform" rating. The company was upgraded on Monday, November 30 by Guggenheim. RBC Capital Markets maintained the shares of CLB in report on Friday, October 23 with "Outperform" rating. Citigroup maintained Core Laboratories N.V. (NYSE:CLB) on Friday, March 18 with "Neutral" rating. Stephens has "Equal-Weight" rating and $89 target. The stock of Core Laboratories N.V. (NYSE:CLB) has "Neutral" rating given on Thursday, September 1 by Credit Suisse. UBS initiated the stock with "Neutral" rating in Tuesday, December 13 report. The stock has "Perform" rating by Oppenheimer on Tuesday, January 12. Its down 0.08, from 0.91 in 2016Q3.

Fowler leads US Open on day of highs and lows
Jason Day , the world number three, will also have the weekend off after a 75 left the Australian at 10 over through two rounds. Or Rory McIlroy , who drove the No. 2 green, made eagle and then saw everything go haywire from there in shooting 78.

Recently analysts working for various investment brokerages have changed their ratings and price targets on shares of Core Laboratories N.V. (NYSE:CLB). 43 funds opened positions while 98 raised stakes. Mitsubishi Ufj Tru & Banking invested in 0.02% or 85,216 shares. Shelton Management accumulated 17,126 shares. Pennsylvania-based Vanguard Group has invested 0.02% in Core Laboratories N.V. (NYSE:CLB). Schwab Charles Invest Mgmt owns 121,533 shares for 0.02% of their portfolio. Clearbridge Limited Co stated it has 0.66% of its portfolio in Core Laboratories N.V. (NYSE:CLB). Park Natl Oh accumulated 0.01% or 1,707 shares. Peoples Fin Serv holds 42 shares or 0% of its portfolio. Finally, Franklin Resources Inc. increased its position in shares of Core Laboratories 8.9% in the fourth quarter. New York-based Goldman Sachs Gru has invested 0% in Core Laboratories N.V. (NYSE:CLB). Comerica Bank increased its stake in shares of Core Laboratories 24.7% in the fourth quarter. The oil and gas company reported $0.42 earnings per share for the quarter, beating the Thomson Reuters' consensus estimate of $0.39 by $0.03.